Fractyl Health, Inc. Stock-Based Compensation
Fractyl Health, Inc. (GUTS) reported Stock-Based Compensation of $5.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.50M, a 39.83% increase year-over-year.
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.53M, a 80.01% increase year-over-year.
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.85M, a 36.01% decline year-over-year.
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.64M, a 35.00% decline year-over-year.
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $6.68M, a 53.67% decline from fiscal 2024.
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $14.43M, a 235.80% increase from fiscal 2023.
- Fractyl Health, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $4.30M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.03M 10-Q · filed 2026-08-10 | $6.88M derived: sum of 3 quarters · filed 2026-08-10 | $8.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $2.53M 10-Q · filed 2026-05-12 | $4.39M derived: sum of 2 quarters · filed 2026-05-12 | $6.02M derived: sum of 3 quarters · filed 2026-05-12 | $7.81M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $3.49M derived: sum of 2 quarters · filed 2026-03-24 | $5.28M derived: sum of 3 quarters · filed 2026-08-10 | $6.68M 10-K · filed 2026-03-24 |
| 2025-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.42M derived: sum of 2 quarters · filed 2026-08-10 | $4.83M 10-Q · filed 2025-11-12 | $7.73M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $3.19M 10-Q · filed 2026-08-10 | $6.09M derived: sum of 3 quarters · filed 2026-08-10 | $8.61M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $1.41M 10-Q · filed 2026-05-12 | $4.30M derived: sum of 2 quarters · filed 2026-05-12 | $6.83M derived: sum of 3 quarters · filed 2026-05-12 | $10.62M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $5.42M derived: sum of 2 quarters · filed 2026-03-24 | $9.21M derived: sum of 3 quarters · filed 2026-03-24 | $14.43M 10-K · filed 2026-03-24 |
| 2024-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $6.31M derived: sum of 2 quarters · filed 2025-11-12 | $11.53M 10-Q · filed 2025-11-12 | $12.80M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $9.01M 10-Q · filed 2025-08-12 | $10.28M derived: sum of 3 quarters · filed 2025-08-12 | $11.37M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $5.22M 10-Q · filed 2025-05-13 | $6.49M derived: sum of 2 quarters · filed 2025-05-13 | $7.58M derived: sum of 3 quarters · filed 2025-05-13 | $8.66M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $2.37M derived: sum of 2 quarters · filed 2025-03-03 | $3.44M derived: sum of 3 quarters · filed 2025-03-03 | $4.30M 10-K · filed 2025-03-03 |
| 2023-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.16M derived: sum of 2 quarters · filed 2024-11-12 | $3.02M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.93M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $857.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |